Shahin Fesharaki

Chief Scientific Officer

  • Appointed: 2019
  • Joined Hikma: 2019
  • Nationality: American

Skills and experience: Shahin brings more than 25 years extensive development experience in both generic and branded pharmaceuticals across a broad range of technologies and dosage forms.  He has held senior R&D leadership positions at some of the most successful generic pharmaceutical companies including Watson, Apotex and more recently Actavis where he led the development and commercialization of hundreds of new products including ANDAs, first-to-file and first-to-market opportunities.

Shahin received a Ph.D. in Pharmaceutical Technology from the University of Mumbai, and his Bachelor’s Degree in Pharmacy and a Master’s Degree in Experimental Pharmacology from Pune University.